Lobulär cancer grad 2
Find information and resources for current and returning patients.
Learn about clinical trials at MD Anderson and search our database for open studies. The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services. Your gift will help support our mission to end cancer and make a difference in the lives of our patients. Our personalized portal helps you refer your patients and communicate with their MD Anderson care team.
As part of our mission to eliminate cancer, MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.
Invasive Lobular Carcinoma
Choose from 12 allied health programs at School of Health Professions. Learn about our graduate medical education residency and fellowship opportunities. Invasive lobular carcinoma ILC is a rare type of breast cancer that grows in the lobes of the breast, where milk is produced. Like most breast cancers, it starts the terminal duct lobular units TDLUs of the breast, where the lobes meet with the ducts, which carry milk to the nipple.
When cells in the TDLUs first mutate and become cancerous, a few lose the ability to produce a molecule called E-cadherin. This molecule helps healthy breast cells stay attached to their surroundings.
Invasive Lobular Cancer (ILC)
Cancerous cells without E-cadherin tend to migrate toward the lobules. The lack of E-cadherin is a defining feature of ILC. Because most breast cancer are ductal, breast cancer research and treatment plans historically have not distinguished between the two diseases. There are some important differences in how invasive lobular is treated and behaves, and researchers are now studying ILC more closely.
Unlike ductal carcinomas, ILCs usually do not form a lump. Instead, the cancer cells grow in straight lines. This makes them harder to feel during a physical breast examination.
Invasive Lobular Breast Cancer
In many cases, patients do not notice the growth until these lines of cancer cells intersect and form a mass. Compared to ductal breast cancers, ILC is more often low-grade. This means the cancer cells look similar to normal, healthy cells. Low-grade cancers typically grow and spread more slowly than high-grade cancers. As a low-grade cancer, the prognosis for early-stage ILC is generally good.
However, the disease has a higher chance of returning after 10 years than invasive ductal carcinoma. When ILC spreads, or metastasizes, it often moves into gastrointestinal tract, ovaries, peritoneum, retroperitoneum and leptomeninges part of the membrane that surrounds and protects the brain and spinal cord.
8 insights on lobular breast cancer
This is called recognition. Researchers have identified certain receptors that fuel the growth and spread of breast cancer when they recognize a specific molecule. They are called hormone-receptor positive breast cancers. Historically, two breast cancer subtypes known as invasive lobular carcinoma and ductal carcinoma have been grouped together.
Invasive lobular carcinoma, also called lobular breast cancer, forms in the cells of the breast that produce milk. These cells are called lobules. How could we study them as one? Though both occur in the breast, the diagnoses are very different. However, 40, women will face a lobular breast cancer diagnosis this year. Eventually, the lines of cancer cells cross and interconnect to form a mass, but at that point, the cancer is advanced.